Abstract

Carbonic anhydrases (CAs, EC 4.2.1.1) catalyze the essential reaction of CO2 hydration in all living organisms, being actively involved in the regulation of a plethora of patho-/physiological conditions. A series of chromene-based sulfonamides were synthesized and tested as possible CA inhibitors. On the other hand, in microorganisms, the β- and γ- classes are expressed in addition to the α- class, showing substantial structural differences to the human isoforms. In this scenario, not only human but also bacterial CAs are of particular interest as new antibacterial agents with an alternative mechanism of action for fighting the emerging problem of extensive drug resistance afflicting most countries worldwide. Pyrazolo[4,3-c]pyridine sulfonamides were synthesized using methods of organic chemistry. Their inhibitory activity, assessed against the cytosolic human isoforms hCA I and hCA II, the transmembrane hCA IX and XII, and β- and γ-CAs from three different bacterial strains, was evaluated by a stopped-flow CO2 hydrase assay. Several of the investigated derivatives showed interesting inhibition activity towards the cytosolic associate isoforms hCA I and hCA II, as well as the 3β- and 3γ-CAs. Furthermore, computational procedures were used to investigate the binding mode of this class of compounds within the active site of hCA IX. Four compounds (1f, 1g, 1h and 1k) were more potent than AAZ against hCA I. Furthermore, compound 1f also showed better activity than AAZ against the hCA II isoform. Moreover, ten compounds out of eleven appeared to be very potent against the γ-CA from E.coli, with a Ki much lower than that of the reference drug. Most of the compounds showed better activity than AAZ against hCA I as well as the γ-CA from E.coli and the β-CA from Burkholderia pseudomallei (BpsCAβ). Compounds 1f and 1k showed a good selectivity index against hCA I and hCA XII, while 1b was selective against all 3β-CA isoforms from E.coli, BpsCA, and VhCA and all 3γ-CA isoforms from E.coli, BpsCA and PgiCA.

Highlights

  • Carbonic anhydrases (CAs, EC 4.2.1.1) are ubiquitous metalloenzymes, present throughout most living organisms and encoded by eight evolutionarily unrelated gene families: the α, β, γ, δ, ζ, η, θ, and ι-CAs [1–3]. All these enzymes catalyze the reversible hydration of carbon dioxide to a bicarbonate ion and proton (CO2 + H2 O HCO3 − + H+ ), which is essential in a variety of physiological processes [3,4], and it has been shown that abnormal levels or activities of these enzymes are often associated with different human diseases [3]

  • All human CAs belong to the α-class, and, to date, fifteen isoforms have been discovered, which differ by molecular features, oligomeric arrangehave discovered, whichdistribution differ by molecular features, oligomeric arrangement, ment,been cellular localization, in organs and tissues, expression levels, cellular kinetic localization, distribution in different organs and tissues, expression kinetic and properties, and response to classes of inhibitors

  • The condensation of dienamine 2 with various amines containing sulfonamide fragments led to the final pyrazolo[4,3-c]pyridines 1a–f

Read more

Summary

Introduction

Carbonic anhydrases (CAs, EC 4.2.1.1) are ubiquitous metalloenzymes, present throughout most living organisms and encoded by eight evolutionarily unrelated gene families: the α-, β-, γ-, δ-, ζ-, η-, θ-, and ι-CAs [1–3] All these enzymes catalyze the reversible hydration of carbon dioxide to a bicarbonate ion and proton (CO2 + H2 O HCO3 − + H+ ), which is essential in a variety of physiological processes [3,4], and it has been shown that abnormal levels or activities of these enzymes are often associated with different human diseases [3]. The organisms, β- andclasses γ- classes are expressed addition to thein α-microorganisms, class, showing subβand γclasses are expressed in addition to the αclass, showing substantial structural stantial structural differences to the human isoforms. Bacterial CAs are of differences to the human

Objectives
Methods
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.